Assessment of phenotypic methods for metalobetalactamase detection in clinical isolates of pseudomonas aeruginosa;Evaluación de métodos fenotípicos para la detección de metalobetalactamasas en aislados clínicos de Pseudomonas aeruginosa

Kasmera

Volumn 41, Issue 2, 2013, Pages 115-126

  Perozo Mena, Armindo José ^a   Castellano González, Maribel Josefina ^a   Chávez Kathyuska, Tutaya ^b   Toledo, Eliana Ling ^b   Arraiz, Nailet ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

Author keywords

BlaIMP; BlaVIM; Detection; MBL; Metalo beta lactamase; P. aeruginosa

Indexed keywords

EID: 85013084686     PISSN: 00755222     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseu do monasaeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SEN TRY Anti microbial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 15;32(Suppl 2):s146-s155
2. Corona-Nakamura AL, Miranda-Novales MG, Leaños-Miranda B, Portillo-Gómez L, Hernández-Chávez A, Anthor-Rendón J, et al. Epidemiologic Study of Pseu do mo nasaerugi nosa in Critical Patients and Reservoirs. Arch Med Res 2001; 32(3):238-42
3. Crespo MP, Woodford N, Sinclair A, Kaufmann ME, Turton J, Glover J, et al. Out break of Carbapenem-Resistant Pseu do mo nas aerugi nosa Producing VIM-8, a Novel Metallo-(beta)-Lactamase, in a Tertiary Care Center inCali, Colombia. J Clin Microbiol 2004; 42(11): 5094-101
4. Martinez P, Espinal P, Attar S. Epidemiologia molecular de Pseu do mo nasaerugi nosa resistente a Beta-lactamicos de amplioes pectroenel Hospital San Jeronimo de Monteria. Infectio 2007; 11(1):6-15
5. Gamboa M, Rodríguez E, Rojas M. Bacterias deim portancia clínica en respiradores y aires acondiciona dos de hospitales de San José, Costa Rica. Revista Bio medica 2003; 14:143-51
6. Vilar-Compte D, Jacquemin B, Díaz-González A, Velasquez C, Wolkow P. Brotepor Pseudomonas aeruginosa, enelárea deatención ambulatoria de heridasquirúr gicas, enpacientes posmastecto mizadas. Salud Pública de México 2003; 45(5):371-8
7. Hancock REW. Resistance Mechanisms in Pseudomonas aeruginosa and Other Nonfermentative Gram-Negative Bacteria. Clinical Infectious Diseases 1998; 27(Supple ment 1):S93-S99
8. Pagniez G, Radice M. Prevalencia de metalo-β-lactamasas en Pseudomonas aeruginosa resistentes a carbapenemes en un Hospital Universitario de Buenos Aires. Revista Argentina de Microbiología 2006; 38(33):37
9. Socie dad Argentina de Bacteriología (SADEBAC). Consensosobre criterio de ensayo, inter pretación e Informe de las pruebas de sensibilidad en los BGNNF de im portancia clínica. Disponible en: www aamorgar
10. Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R. Hospital out break of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. Clin In fect Dis. 2000; 31 (5): 1119-25
11. Tsakris A, Pournaras S, Woodford N, Palepou MF, Babini GS, Douboyas J, et al. Outbreak of Infections Caused by Pseudomonas aeruginosa Producing VIM-1 Car bape nemase in Greece. J Clin Microbiol 2000; 38(3):1290-2
12. Suarez CJ, Kattan JN, Guzmán AM, Villegas MV. Me can is mosderesistencia a carbapenems en P. aeruginosa, Acineto bacter y Entero bacteriaceae y estrategias parasu prevencin y control. Infectio 2006; 10:85-93
13. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, et al. Novel acquired metallobeta-lactamase gene, bla(SIM-1), in a class 1 integron from Acine to bacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 2005; 49(11):4485-91
14. Gomez-lvarez CA, Leal Castro AL, Perez de Gonzalez MdJ, Navarrete Jimenez ML. Mecan ismos de Resistencia en Pseuodomonas aeruginosa:entendiendo a un peligrosoenemigo. Revista Facultad de Medicina de la Universidad Nacional de Colombia 2005; 53:27-34
15. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient Test for Screening Metallo-beta-Lactamase-Producing Gram-Negative Bacteriaby Using Thiol Compounds. J Clin Micro biol 2000; 38(1):40-3
16. Kiska D, Gillighan P. Pseudomonas. In: Murray P, Baron E, Jorgensen J, Landry M, Pfaller M, editors. Manual of Clinical Microbiology. 9th ed. Washing ton DC: ASM Press; 2007. p. 734-48
17. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA Disk Method for Differentiation of Metallo-(beta)-Lactamase-Producing Clinical Isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40(10):3798-801
18. Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A. Evaluation of a New Etest for Detect ing Metallo-(beta)-Lactamases in Routine Clinical Testing. J Clin Microbiol 2002; 40(8):2755-9
19. Hodge W, Ciak J, Tramont EC. Simple method for detection of penicillinaseproducing Neisseriagon orrhoeae. J Clin Microbiol 1978; (1):102-3
20. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-(beta)-Lactamase-Producing Iso lates of Pseudomonas spp. and Acine to bacter spp. J Clin Microbiol 2003; 41(10):4623-9
21. Bush K. Metallo-B-Lactamases: A Class Apart. Clinical Infectious Diseases 1998; 27(Supplement 1):S48-S53
22. Fritsche TR, Sader HS, Toleman MA, Walsh TR, Jones RN. Emerging Metallo-BLactamase-Mediated Resistances: A Summary Report from the World wide SEN TRY Antimicrobial Surveillance Program. Clinical Infectious Diseases 2005; 41(Supplement 4): S276-S278
23. Laraki N, Franceschini N, Rossolini GM, Santucci P, Meunier C, de Pauw E, et al. Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-beta-Lactamase IMP-1 Produced by Escherichia coli. Antimicrob Agents Chemother 1999; 43(4):902-6
24. Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, et al. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999; 43(7): 1584-90
25. Mendes RE, Castanheira M, Garcia P, Guzman M, Toleman MA, Walsh TR, et al. First Isolation of blaVIM-2 in Latin America: Report from the SEN TRY Anti microbial Surveil lance Program. Antimicrob Agents Chemo ther 2004; 48(4): 1433-4
26. Oelschlaeger P, Schmid RD, Pleiss J. In sight into the mechanism of the IMP-1 metallo-Blactamase by molecular dynamics simulations. Protein Engineering 2003; 16(5):341-50
27. Pagani L, Colinon C, Migliavacca R, Labonia M, Docquier JD, Nucleo E, et al. Nosocomial Out break Caused by Multidrug-Resistant Pseudomonas aeruginosa Producing IMP-13 Metallo-(beta)-Lactamase. J Clin Microbiol 2005; 43(8):3824-8
28. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, et al. Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-beta-Lactamase and Its Plasmidand Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France. Antimicrob Agents Chemother 2000; 44(4):891-7
29. Toleman MA, Biedenbach D, Bennett D, Jones RN, Walsh TR. Ge netic characterization of a novel metallo-B-lactamase gene, blaIMP-13, har boured by a novel Tn5051-type trans poson disseminating carbapenemase genes in Europe: report from the SENTRY world wide antimicrobial surveillance programme. J Anti microb Chemother 2003; 52(4):583-90
30. Villegas MV, Lolans K, del Rosario Olivera M, Suarez CJ, Correa A, Queenan AM, et al. First Detection of Metallo-(beta)-La ctamase VIM-2 in Pseudomonas aeruginosa Isolates from Colombia. Antimicrob Agents Chemother 2006; 50(1):226-9
31. Perozo-Mena A, Castellano-González M, Ginestre-Pérez M, Rincón-Villalobos G. Resistencia a Van comicinaen Cepas de Enterococcus faecium Aisladas en un Hospital Universitario. Kasmera 2011; 39(1):7-17
32. Woodford N, Tierno PM, Jr., Young K, Tysall L, Palepou MF, Ward E, et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A betalactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother 2004; 48(12): 4793-9
33. Pita-Fernández S, Pértegas-Díaz S. Pruebas Diagnósticas: Sensibili dad y Especificidad. Cuadernos de Atención Primaria 2003;10:120-4
34. Sánchez NA. Son la sensibilidad y la especificidad medida sobsoletas para de terminarlabondad de una pruebadiagnóstica? Revista de la Facultad Nacional de Salud Pública 2002; 20(1): 149-59
35. Galani I, Rekatsina PD, Hatzaki D, Plachouras D, Souli M, Giamarellou H. Evaluation of different laboratory tests for the detection of metallo-B-lactamase production in Entero bacteriaceae. J Antimicrob Chemother 2008; 61(3): 548-53
36. Guevara A, Gamboa A, Machado M, Vera M. Evaluación del ácido etilendiaminotetraacético y del mercaptoacético de sodio en la detección de metalo.-lactamasas en Pseudomonas aeruginosa mediante latécnica del discocombinado. Revista de la Sociedad Venezolana de Microbiología 2010; 30(1): 11-7
37. Lee K, Chong Y, Shin H, Kim Y, Yong D, Yum J. Modified Hodge and EDTA-disk syn ergy tests to screen metallo-B-lactamaseproducing strains of Pseudomonas and Acine to bacter species. Clinical Microbiology & Infection 2001;7(2):88-91
38. Perozo-Mena A, Castellano-González M, Ling-Toledo E, Ar raiz N. Detección fenotípica de metalobetalactamasas en aisla dos clínicos de Pseudomonas aeruginosa. KAS MERA 40[2], 113-121. 2012
39. Pi tout JDD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa Producing Metallo-(beta)-Lactamases in a Large Centralized Laboratory. J Clin Microbiol 2005; 43(7):3129-35
40. Valenza G, Joseph B, Elias J, Claus H, Oesterlein A, Engelhardt K, et al. First Survey of Metallo-(beta)-Lactamases in Clinical Isolates of Pseudomonas aeruginosa in a German University Hospital. Antimicrob Agents Chemother 2010; 54(8):3493-7